The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 1 - 30 of 459 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
PL
|
Resepti
|
A-Pen 500 mg, 1 g injektio-infuusiokuiva-aine, liuosta varten SPC 2020-02-05
|
|
PL
|
Resepti
|
Abacavir Accord 300 mg tabletti, kalvopäällysteinen SPC 2023-10-13
|
|
PL
|
Resepti
|
Abacavir-Lamivudin Mylan 600 mg-300 mg tabletti, kalvopäällysteinen SPC 2023-11-21
|
|
PL
|
Resepti
|
Abacavir-Lamivudine Accord 600 mg-300 mg tabletti, kalvopäällysteinen SPC 2023-10-13
|
|
PL
|
Resepti
|
Abacavir-Lamivudine Stada 600 mg-300 mg tabletti, kalvopäällysteinen SPC 2023-11-22
|
|
PL
|
Resepti
|
Abakavir-Lamivudin Mylan Pharma 600 mg-300 mg tabletti, kalvopäällysteinen SPC 2023-11-21
|
|
|
|
European Medicines Agency's website:
ABASAGLAR - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Abbonate 20 mg tabletti, kalvopäällysteinen SPC 2024-05-02
|
|
PL
|
Resepti
|
Abboticin 1 g infuusiokuiva-aine, liuosta varten SPC 2024-03-22
|
|
PL
|
Resepti
|
Abboticin Novum 500 mg tabletti, kalvopäällysteinen SPC 2024-04-29
|
|
|
|
European Medicines Agency's website:
Abecma - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Abevmy - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Abilify - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Abilify Maintena - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Abirateron Avansor 500 mg tabletti, kalvopäällysteinen SPC 2024-09-24
|
|
PL
|
Resepti
|
Abirateron Medical Valley 500 mg tabletti, kalvopäällysteinen SPC 2023-01-24
|
|
PL
|
Resepti
|
Abirateron Sandoz 500 mg tabletti, kalvopäällysteinen SPC 2024-08-20
|
|
|
|
European Medicines Agency's website:
Abiraterone Accord - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Abiraterone Glenmark 500 mg tabletti, kalvopäällysteinen SPC 2023-03-31
|
|
|
|
European Medicines Agency's website:
Abiraterone Krka - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Abiraterone Mylan - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Abiraterone ratiopharm 500 mg tabletti, kalvopäällysteinen SPC 2023-07-21
|
|
PL
|
Resepti
|
Abiraterone Stada 500 mg tabletti, kalvopäällysteinen SPC 2024-06-03
|
|
|
|
European Medicines Agency's website:
Abraxane - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Abrysvo - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Abseamed - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Absenor 100 mg, 300 mg, 500 mg enterotabletti SPC 2024-05-02
|
|
PL
|
Resepti
|
Absenor 200 mg-ml tipat, liuos SPC 2024-05-02
|
|
PL
|
Resepti
|
Absenor 300 mg, 500 mg depottabletti SPC 2024-05-02
|
|
PL
|
Resepti
|
Absenor 60 mg-ml oraaliliuos SPC 2024-05-02
|
|
|
